GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Everest Organics Ltd (BOM:524790) » Definitions » Price-to-Owner-Earnings

Everest Organics (BOM:524790) Price-to-Owner-Earnings : 149.58 (As of May. 31, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Everest Organics Price-to-Owner-Earnings?

As of today (2025-05-31), Everest Organics's share price is ₹426.30. Everest Organics's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹2.85. It's Price-to-Owner-Earnings for today is 149.58.


The historical rank and industry rank for Everest Organics's Price-to-Owner-Earnings or its related term are showing as below:

BOM:524790' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.13   Med: 27.54   Max: 153.93
Current: 153.93

During the past 9 years, the highest Price-to-Owner-Earnings of Everest Organics was 153.93. The lowest was 11.13. And the median was 27.54.


BOM:524790's Price-to-Owner-Earnings is ranked worse than
93.96% of 447 companies
in the Drug Manufacturers industry
Industry Median: 25.25 vs BOM:524790: 153.93

As of today (2025-05-31), Everest Organics's share price is ₹426.30. Everest Organics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-5.19. Therefore, Everest Organics's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-31), Everest Organics's share price is ₹426.30. Everest Organics's EPS without NRI for the trailing twelve months (TTM) ended in was ₹-5.19. Therefore, Everest Organics's PE Ratio without NRI for today is At Loss.

During the past 9 years, Everest Organics's highest PE Ratio without NRI was 841.76. The lowest was 0.00. And the median was 754.41.


Everest Organics Price-to-Owner-Earnings Historical Data

The historical data trend for Everest Organics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Everest Organics Price-to-Owner-Earnings Chart

Everest Organics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only 221.96 33.47 28.15 11.13 40.25

Everest Organics Quarterly Data
Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 40.25 - - -

Competitive Comparison of Everest Organics's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Everest Organics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Everest Organics's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Everest Organics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Everest Organics's Price-to-Owner-Earnings falls into.


;
;

Everest Organics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Everest Organics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=426.30/2.85
=149.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Everest Organics  (BOM:524790) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Everest Organics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Everest Organics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Everest Organics Business Description

Traded in Other Exchanges
N/A
Address
Opposite Madhapur Police Station Road, 1st Floor, Amar Co-Operative Society, Lakeview Plaza, Plot No. 127 and 128, Near Durgam Cheruvu, Madhapur, Hyderabad, TG, IND, 500 033
Everest Organics Ltd is a pharmaceutical company. It is focused on manufacturing active pharmaceutical ingredients and intermediaries. The products offered by the company include Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole, and others. The company operates in one primary business segment namely Active Pharmaceutical Ingredients (API) and their intermediaries. Geographically, it derives a majority of its revenue from India.

Everest Organics Headlines

No Headlines